Comirnaty .0158 mg/.48mL
COVID-19 Vaccine, mRNA · INJECTION, SUSPENSION · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
Comirnaty is a injection, suspension containing covid-19 vaccine, mrna at .0158 mg/.48mL, taken intramuscular. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Comirnaty
- Generic Name
- COVID-19 Vaccine, mRNA
- NDC Code (Product)
0069-2501- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- .0158 mg/.48mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125742
- Marketing Start
- 08/27/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Comirnaty used for?
Comirnaty contains COVID-19 Vaccine, mRNA. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.
Is Comirnaty a controlled substance?
Comirnaty is not classified as a controlled substance by the DEA.
What is the generic name for Comirnaty?
The generic name for Comirnaty is COVID-19 Vaccine, mRNA. There are 3 other brand versions of COVID-19 Vaccine, mRNA.
What is the NDC code for Comirnaty .0158 mg/.48mL?
The NDC (National Drug Code) for Comirnaty .0158 mg/.48mL is 0069-2501, listed by Pfizer Laboratories Div Pfizer Inc.